Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 12, p. 1293, doi. 10.1111/apt.13631

By:

• Ungar, B.;
• Mazor, Y.;
• Weisshof, R.;
• Yanai, H.;
• Ron, Y.;
• Goren, I.;
• Waizbard, A.;
• Yavzori, M.;
• Fudim, E.;
• Picard, O.;
• Loebstein, R.;
• Kopylov, U.;
• Dotan, I.;
• Chowers, Y.;
• Eliakim, R.;
• Ben‐Horin, S.

Publication type:

Article